Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Perioperative management of a patient undergoing a novel mini-invasive percutaneous transcatheter left ventricular reconstruction procedure.
Effect of fish oil on glutathione redox system in multiple sclerosis.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children.
Pediatric multiple sclerosis: Clinical features and outcome.
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome.
High-resolution Transcriptome Analysis Reveals Neuropathic Pain Gene- Expression Signatures in Spinal Microglia Following Nerve Injury.
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
Finast: Buy Natural
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
[Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Modulation of neuronal activity by the endogenous pentapeptide QYNAD.
Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
Long-term evolution of multiple sclerosis disability in the treatment era.
Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis.
Axonal activity-dependent myelination in development: Insights for myelin repair.
Capillary telangiectasia mimicking an active demyelinating lesion in a patient with multiple sclerosis.
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents.
Prognosis in multiple sclerosis and the unveiling of pathogenic clues.
Biological therapy and neurological manifestations. What do we know?

Pages